Fujifilm Biosciences Inc.
Santa Ana, CA Doing business as Fujifilm Irvine Scientific, Inc. Part of Fujifilm Holdings America Corp
- UEI
- NCTEKHZJ9293
- CAGE
- 0KDR5
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Fujifilm Sonosite Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Valhalla, NY
UDAMRNS7L2K8
-
Parent
Valhalla, NY
UDAMRNS7L2K8
- SAM.gov registration date
- Physical address
- 2501 Pullman St #201, Santa Ana, CA 92705, USA
- Website
- fujifilm.com
- Founded
- 1934
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Consumer Discretionary
- Consumer Durables & Apparel
- Household Durables
- Photography
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $160,103 |
| FY2025 | $358,135 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $160,103 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Fujifilm Biosciences Inc., doing business as Fujifilm Irvine Scientific, Inc., manufactures human induced pluripotent stem cell-derived (hiPSC) cells and related cellular research products for federal biomedical research agencies as a prime contractor on full-and-open purchase orders and delivery orders, with no set-aside designations across its recent federal footprint. A foreign-owned, for-profit manufacturer headquartered in Santa Ana, California and a subsidiary of Fujifilm Holdings America Corp, the vendor operates across primary NAICS categories of biological product manufacturing (except diagnostic) and in-vitro diagnostic substance manufacturing, classified under PSC codes for laboratory equipment and supplies and drugs and biologicals.
The vendor's federal customer base concentrates tightly with the Department of Health and Human Services. The Food and Drug Administration dominates both award volume and dollar value — five awards account for $997 thousand of the vendor's $1.2 million combined potential value across 49 recent awards (83% concentration by dollars). The National Institute of Environmental Health Sciences, the National Center for Advancing Translational Sciences, and the Office of the Director of the NIH round out the HHS cluster with smaller volumes. The Department of the Army Medical Command and the Health Resources and Services Administration appear as occasional customers with low-value work. The top customers by award count and by potential value track nearly identically, with FDA anchoring both rankings.
Fujifilm Biosciences holds a single-award Indefinite Delivery Contract with FDA (ceiling $500,000, running through August 31, 2031) under which three delivery orders totaling $407 thousand have been placed. Recent representative work includes a $246,980 firm-fixed-price delivery order from FDA on September 10, 2025, for hiPSC cells with performance in Silver Spring, Maryland (ultimate completion September 8, 2026); a $144,970 delivery order from FDA issued September 30, 2026 (today's date), for hiPSC cells under Executive Order 14398 with completion scheduled September 29, 2027; and a $21,500 purchase order from the National Center for Advancing Translational Sciences awarded September 30, 2025, for parts extraction and disposal from discontinued Kalypsys/GNF laboratory equipment with completion January 31, 2026.
Activity remains low and episodic — one or two awards per year in 2020–2022, rising to four awards in 2025 and two in 2026 — with $699 thousand (58% of potential value) obligated to date across the portfolio. Two awards with ultimate completion inside the next twenty-four months carry combined potential value of $160 thousand. The vendor operates exclusively as a prime contractor (100% of awards) with no subcontract footprint. All work is performed full-and-open, with no 8(a), HUBZone, SDVOSB, or other small-business set-aside designations.
Quick answers
Is Fujifilm Biosciences Inc. registered in SAM.gov?
Yes. Fujifilm Biosciences Inc.'s SAM.gov registration is active through June 12, 2027.
How much has Fujifilm Biosciences Inc. received in federal contracts?
Federal contracts obligated $358,135 to Fujifilm Biosciences Inc. in fiscal year 2025 and $518,238 in fiscal years 2023 through 2027.
How does Fujifilm Biosciences Inc. rank among federal contractors?
Fujifilm Biosciences Inc.'s parent company, Fujifilm Sonosite Inc., ranked #32 in NAICS 325414 and #65 in PSC B529 in FY2025.
What is Fujifilm Biosciences Inc.'s most recent federal award?
Fujifilm Biosciences Inc.'s most recent federal contract award is EO 14398 - purchase of human induced pluripotent stem cell-derived (hipsc) cells (75F40126F19003), from Food and Drug Administration, on September 30, 2026.
On GovTribe
See Fujifilm Biosciences Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors